ProShares UltraShort Nasdaq Biotechnology (BIS) Institutional Ownership $16.67 -0.47 (-2.74%) (As of 11/22/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipShort InterestTrends Institutional Ownership Changes (13F Filings) for ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$608.76KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$97.65K Get BIS Insider Trade Alerts Want to know when executives and insiders are buying or selling ProShares UltraShort Nasdaq Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BIS Institutional Buying and Selling by Quarter Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. ProShares UltraShort Nasdaq Biotechnology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Jane Street Group LLC10,520$158K0.0%N/A4.782% 4/13/2024 IMC Chicago LLC25,210$443K0.0%+68.1%11.459% 2/13/2024 Tower Research Capital LLC TRC4,721$85K0.0%-53.4%1.004% 2/9/2024 IMC Chicago LLC15,001$271K0.0%N/A3.192% 11/10/2022 Tower Research Capital LLC TRC8,123$205K0.0%-9.2%2.708% 11/8/2022 IMC Chicago LLC23,335$590K0.0%+11.1%7.778% 8/5/2022 IMC Chicago LLC21,003$566K0.0%+12.5%5.251% 8/5/2022 OLD Mission Capital LLC15,311$413K0.0%-52.5%3.828% 4/19/2022 IMC Chicago LLC18,668$450K0.0%N/A5.395% 2/10/2022 OLD Mission Capital LLC13,257$266K0.0%N/A3.348% 11/5/2021 IMC Chicago LLC27,459$495K0.0%+93.3%6.934% 8/13/2021 OLD Mission Capital LLC30,214$556K0.0%-33.8%6.774% 8/11/2021 Susquehanna International Group LLP34,616$637K0.0%-26.5%7.761% 8/6/2021 IMC Chicago LLC14,203$261K0.0%+5.4%3.185% 5/18/2021 Citadel Advisors LLC11,342$256K0.0%N/A2.543% 2/17/2021 IMC Chicago LLC11,604$273K0.0%N/A2.125% 2/13/2021Wealthsource Partners LLC18,050$425K0.0%-5.2%3.639% 1/13/2021 Sowell Financial Services LLC2,285$54K0.0%N/A0.512% 11/16/2020Wealthsource Partners LLC19,050$590K0.1%-72.4%4.271% (Data available from 1/1/2016 forward) BIS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BIS shares? During the previous two years, the following institutional investors and hedge funds held shares of ProShares UltraShort Nasdaq Biotechnology shares: IMC Chicago LLC ($443K), and Jane Street Group LLC ($158K), Tower Research Capital LLC TRC ($85K).Learn more on BIS's institutional investors. Which institutional investors have been buying ProShares UltraShort Nasdaq Biotechnology stock? The following institutional investors have purchased ProShares UltraShort Nasdaq Biotechnology stock in the last 24 months: IMC Chicago LLC ($25.21K), and Jane Street Group LLC ($10.52K). How much institutional buying is happening at ProShares UltraShort Nasdaq Biotechnology? Institutional investors have bought a total of 35,730 shares in the last 24 months. This purchase volume represents approximately $608.76K in transactions. Which ProShares UltraShort Nasdaq Biotechnology major shareholders have been selling company stock? The following institutional investors have sold ProShares UltraShort Nasdaq Biotechnology stock in the last 24 months: Tower Research Capital LLC TRC ($5.40K). How much institutional selling is happening at ProShares UltraShort Nasdaq Biotechnology? Institutional investors have sold a total of 5,404 shares in the last 24 months. This volume of shares sold represents approximately $97.65K in transactions. Related Companies JPMorgan Healthcare Leaders ETF Institutional Ownership First Trust Nasdaq Pharmaceuticals ETF Institutional Ownership Invesco Nasdaq Biotechnology ETF Institutional Ownership ProShares Ultra Nasdaq Biotechnology Institutional Ownership Invesco Dorsey Wright Healthcare Momentum ETF Institutional Ownership Invesco S&P SmallCap Health Care ETF Institutional Ownership VanEck Biotech ETF Institutional Ownership VanEck Pharmaceutical ETF Institutional Ownership iShares Biotechnology ETF Institutional Ownership This page (NASDAQ:BIS) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraShort Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares UltraShort Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
